Short answer
Teleflex Inc (TFX) filed its Q2 2018 10-Q quarterly report on May 3, 2018 for the quarter ended Apr 1, 2018.
Teleflex Inc Q2 2018 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $587.2M, up 20.4% YoY from $487.9M, driven by acquisitions and $24.5M favorable currency impact
- Gross margin 56.4% vs 52.4% YoY; SG&A margin 36.7% vs 33.6%
- Best segment Interventional North America: revenue $60.2M, up 50.7%; worst Surgical North America: revenue $40.7M, down 11.5%
- Operating cash flow $86.8M vs $90.9M; capital expenditures $15.7M, acquisition payments $3.7M, debt repayment $18.5M
- 2018 Footprint plan: $102M-$133M charges, $25M-$30M annual savings at completion; credit and customer-payment risks remain headwinds
Risk Factors
- No Risk Factors section provided, preventing identification of newly added or materially changed risks since the 2017 10-K
- Acquisition obligation: NeoTract contingent consideration up to $375 million tied to sales goals through 2020
- Restructuring execution: 2016 footprint plan expected substantially complete by end of 2018
- Revenue concentration: Hospitals and healthcare providers represented 87% of quarterly net revenues
- Financial exposure: Long-term borrowings totaled $2.154 billion at April 1, 2018
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Teleflex Inc quarterly reports
- Q3 2019 10-QFiled Oct 31, 2019
- Q2 2019 10-QFiled Aug 1, 2019
- Q1 2019 10-QFiled May 2, 2019
- Q3 2018 10-QFiled Nov 1, 2018
- Q3 2018 10-QFiled Aug 2, 2018
- Q4 2017 10-QFiled Nov 2, 2017
- Q3 2017 10-QFiled Aug 3, 2017
- Q2 2017 10-QFiled May 4, 2017
- Q3 2016 10-QFiled Oct 27, 2016
- Q2 2016 10-QFiled Jul 28, 2016
- Q1 2016 10-QFiled Apr 28, 2016
- Q3 2015 10-QFiled Oct 29, 2015
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.